Literature DB >> 21726530

A partially folded structure of amyloid-beta(1-40) in an aqueous environment.

Subramanian Vivekanandan1, Jeffrey R Brender, Shirley Y Lee, Ayyalusamy Ramamoorthy.   

Abstract

Aggregation of the Aβ(1-40) peptide is linked to the development of extracellular plaques characteristic of Alzheimer's disease. While previous studies commonly show the Aβ(1-40) is largely unstructured in solution, we show that Aβ(1-40) can adopt a compact, partially folded structure. In this structure (PDB ID: 2LFM), the central hydrophobic region of the peptide forms a 3(10) helix from H13 to D23 and the N- and C-termini collapse against the helix due to the clustering of hydrophobic residues. Helical intermediates have been predicted to be crucial on-pathway intermediates in amyloid fibrillogenesis, and the structure presented here presents a new target for investigation of early events in Aβ(1-40) fibrillogenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726530      PMCID: PMC3148408          DOI: 10.1016/j.bbrc.2011.06.133

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

Review 1.  Conformational constraints for amyloid fibrillation: the importance of being unfolded.

Authors:  Vladimir N Uversky; Anthony L Fink
Journal:  Biochim Biophys Acta       Date:  2004-05-06

2.  Transient formation of intermediate conformational states of amyloid-β peptide revealed by heteronuclear magnetic resonance spectroscopy.

Authors:  Takahiro Yamaguchi; Katsumi Matsuzaki; Masaru Hoshino
Journal:  FEBS Lett       Date:  2011-03-12       Impact factor: 4.124

3.  Nuclear magnetic resonance identification of "half-turn" and 3(10)-helix secondary structure in rabbit liver metallothionein-2.

Authors:  G Wagner; D Neuhaus; E Wörgötter; M Vasák; J H Kägi; K Wüthrich
Journal:  J Mol Biol       Date:  1986-01-05       Impact factor: 5.469

4.  Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.

Authors:  Saravanakumar Narayanan; Bernd Reif
Journal:  Biochemistry       Date:  2005-02-08       Impact factor: 3.162

5.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

Authors:  C J Barrow; A Yasuda; P T Kenny; M G Zagorski
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

6.  The Alzheimer's peptide a beta adopts a collapsed coil structure in water.

Authors:  S Zhang; K Iwata; M J Lachenmann; J W Peng; S Li; E R Stimson; Y Lu; A M Felix; J E Maggio; J P Lee
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

7.  Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.

Authors:  Liming Hou; Haiyan Shao; Yongbo Zhang; Hua Li; Nanda K Menon; Elizabeth B Neuhaus; John M Brewer; In-Ja L Byeon; Dale G Ray; Michael P Vitek; Takashi Iwashita; Ronald A Makula; Alan B Przybyla; Michael G Zagorski
Journal:  J Am Chem Soc       Date:  2004-02-25       Impact factor: 15.419

8.  Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization.

Authors:  Youcef Fezoui; David B Teplow
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

Review 9.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease.

Authors:  J Hardy; D Allsop
Journal:  Trends Pharmacol Sci       Date:  1991-10       Impact factor: 14.819

10.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions.

Authors:  M Piotto; V Saudek; V Sklenár
Journal:  J Biomol NMR       Date:  1992-11       Impact factor: 2.835

View more
  119 in total

1.  Solid-support electron paramagnetic resonance (EPR) studies of Aβ40 monomers reveal a structured state with three ordered segments.

Authors:  Lei Gu; Sam Ngo; Zhefeng Guo
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

2.  Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.

Authors:  Yu-Shan Lin; Gregory R Bowman; Kyle A Beauchamp; Vijay S Pande
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

3.  N-Terminal Charged Residues of Amyloid-β Peptide Modulate Amyloidogenesis and Interaction with Lipid Membrane.

Authors:  Clifford Morris; Shirin Cupples; Thomas W Kent; Esmail A Elbassal; Ewa P Wojcikiewicz; Peng Yi; Deguo Du
Journal:  Chemistry       Date:  2018-06-06       Impact factor: 5.236

Review 4.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

5.  Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

Authors:  Sanghyun Lee; Xueyun Zheng; Janarthanan Krishnamoorthy; Masha G Savelieff; Hyun Min Park; Jeffrey R Brender; Jin Hoon Kim; Jeffrey S Derrick; Akiko Kochi; Hyuck Jin Lee; Cheal Kim; Ayyalusamy Ramamoorthy; Michael T Bowers; Mi Hee Lim
Journal:  J Am Chem Soc       Date:  2013-12-27       Impact factor: 15.419

6.  A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.

Authors:  Masha G Savelieff; Yuzhong Liu; Russell R P Senthamarai; Kyle J Korshavn; Hyuck Jin Lee; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Commun (Camb)       Date:  2013-12-10       Impact factor: 6.222

7.  Structures and dynamics of β-barrel oligomer intermediates of amyloid-beta16-22 aggregation.

Authors:  Xinwei Ge; Yunxiang Sun; Feng Ding
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-14       Impact factor: 3.747

Review 8.  Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

Authors:  Hyunbum Jang; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Bruce L Kagan; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2013-02-28       Impact factor: 3.676

9.  Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β species.

Authors:  Suk-Joon Hyung; Alaina S DeToma; Jeffrey R Brender; Sanghyun Lee; Subramanian Vivekanandan; Akiko Kochi; Jung-Suk Choi; Ayyalusamy Ramamoorthy; Brandon T Ruotolo; Mi Hee Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

Review 10.  Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.

Authors:  Samuel A Kotler; Patrick Walsh; Jeffrey R Brender; Ayyalusamy Ramamoorthy
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.